ArticleAntimicrobial resistance and infection control2026
Implementing AMR surveillance at a tertiary hospital in a low-income country: results from the Surveillance Partnership to Improve Data for Action on AMR (SPIDAAR) in Malawi.
Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobial resistance (AMR) is a growing global health threat, particularly in low- and middle-income countries (LMICs) where infectious diseases are more prevalent. Effective surveillance in these settings is key for tracking resistance trends and informing public health interventions, yet few implementation studies have delineated the particular challenges and opportunities for antimicrobial stewardship (AMS) activities in LMICs. The objective of this study was to evaluate the impact of a multi-component AMR surveillance capacity-building intervention on institutional surveillance capacity, healthcare worker knowledge and practices, and antimicrobial prescribing patterns at a tertiary referral hospital in Malawi.
methodsThe study was conducted at Queen Elizabeth Central Hospital (QECH), a large tertiary hospital in southern Malawi. QECH was one of four sites participating in the Surveillance Partnership to Improve Data for Action on AMR (SPIDAAR), a multi-component capacity-building initiative supported by Pfizer Inc. and the Wellcome Trust, implemented over a 3-year period. The impact of this intervention on AMS practices and AMR surveillance capacity at this site was evaluated using a quasi-experimental approach including healthcare worker assessments and patient file reviews.
resultsA total of 263 and 248 healthcare workers were surveyed at baseline and intervention end period, respectively. 100 patient file reviews were conducted in parallel with the surveys at baseline and end of intervention. There were demonstrable improvements in AMR surveillance across the multiple domains of interest, including clinical assessment, microbiology processes, and data management. Knowledge of the national AMR action plan (NAP) improved from 13.6% to 45.6%, and laboratory request form completeness increased from 48.6% to 73.9%. Empirical antimicrobial prescribing at admission did not change significantly. The persistent gap between self-reported and observed clinical practices highlighted an enduring knowledge-practice challenge.
conclusionA structured, multi-component AMR surveillance intervention can achieve meaningful improvements in surveillance capacity and healthcare worker knowledge in a tertiary hospital in a low-income country setting. Progress was facilitated by national policy alignment and hospital leadership engagement, and constrained by the absence of integrated electronic data systems and a persistent gap between AMS knowledge and clinical practice. These findings have relevance for similar LMIC settings seeking to strengthen AMR surveillance capacity.
Indexed as
Identifiers
42920193What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.